Thread by @EMA_News

EMA's regular Press Briefings twitter.com/i/broadcasts/1…

According to @ECDC_EU, a new wave is expected in the coming weeks, due to new #Omicron subvariants
❗️The pandemic is not yet over.
We urge citizens to get vaccinated now, especially if your health situation puts you at higher risk of severe #COVID19. #EMAPresser

We are carefully following the new virus sub-variants. The virus is faster than we can ever be in adapting vaccines!
We should only consider adapting vaccines when the difference between strains in circulation and vaccines composition becomes major. #EMAPresser #COVID19

It is expected that #SARSCoV2 & #flu will circulate at the same time this autumn and winter.
❗️Vulnerable people will be at increased risk.
Joint vaccination campaigns are taking place in many 🇪🇺 countries. We urge eligible citizens to take advantage of it. #EMAPresser

#COVID19vaccines in small children:
EMA recommends vaccinating primarily small children with underlying illness to protect them from hospitalisation & death.
❗️The decision on children’s vaccination lies with the EU Member States. #EMAPresser

#COVID19vaccines in small children: our experts have looked at the risk of #myocarditis/#pericarditis in vaccinated children. No cases were identified in clinical trials.
❗️The risk of myocarditis is higher among children with COVID-19. #EMAPresser

EMA's reviews are still ongoing for 2⃣ adapted #COVID19vaccines:
➡️Sanofi-Pasteur vaccine Vidprevtyn (possible conclusion in November)
➡️HIPRA (possible conclusion in the coming weeks)
#EMAPresser

#Monkeypox: According to @ECDC_EU data, the epidemiological situation is reassuring.
We see a steep decline of cases and containment of the outbreak at the moment. #EMAPresser

📢To people over 60, pregnant women and those with comorbidities or underlying conditions:
Get vaccinated or re-vaccinated against #COVID19. Now is the time to get protected! #EMAPresser